SBRT for Organ-Confined Prostate Cancer

Alan J. Katz, MD, JD
Flushing Radiation Oncology
Mar 29, 2016
60 minutes
Join us as Alan Katz, MD from Flushing Radiation Oncology discusses his 9-year experience treating organ-confined prostate cancer with SABR using a variety of platforms and technologies. This webinar will trace the rationale for treating prostate cancer with some form of hypo-fractionation back 50 years. It will examine results with moderate hypo-fractionation as a springboard towards more extreme hypo-fractionation as is used with SBRT. Dr. Katz shares his follow up results of 9 years SBRT for all levels of risk. Control rates, QOL and toxicity will be discussed in detail. It will include discussion of two platforms for SBRT. Finally, other experiences with prostate SBRT will be compared.
Who Should Attend 
Radiation oncology professionals interested in improving their understanding of: 
  • Prostate cancer patient selection for SBRT treatment.
  • SBRT treatment planning and delivery techniques and optimal SBRT dose used for the treatment of prostate cancer.
  • Prostate cancer disease control and toxicity rates for low-, intermediate- and high-risk groups of organ-confined prostate cancer.
Varian sponsored this webinar held by The Radiosurgery Society.